Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Symposium at ESC Congress 2018 sponsored by EKOS Corporation
Author(s): Nicolas Meneveau , Andrew SP Sharp , Adriaan Kraaijeveld Added: 5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data Satellite symposium at ESC Congress 2018 sponsored by EKOS Corporation Part 1: Prof Nicolas Meneveau - (Besancon, FR) Part 2: Prof Andrew Sharp - (Exeter, UK) Part 3: Prof Adriaan Kraaijeveld - (Utrecht, NL) View more

Imaging & Diagnostics

Intervention
Author(s): Nina Wunderlich , Jennifer Franke , Neil Wilson , et al Added: 3 years ago
Imaging guidance is of major importance for successful outcomes in the interventional treatment of structural, congenital and valvular heart disease. Cardiac transcatheter treatment of these diseases is a rapidly growing field and, as a result, there has been substantial progress in image-guidance technology. During interventions, the major imaging focus is currently on echocardiography, which… View more

Standards & Guidelines

Imaging & Diagnostics
Fractional Flow Reserve in Multi-Vessel Disease
Author(s): Justin E Davies Start date: Oct 13, 2014
On-Demand Video: Clinical Utilisation of Fractional Flow Reserve in Multi-Vessel Disease Monday 13th October 2014 (14:30-15:30 BST) View more

Intervention
Frailty Scores and Their Utility in Older Patients with Cardiovascular Disease
Author(s): Kenneth Jordan Ng Cheong Chung , Chris Wilkinson , Murugapathy Veerasamy , et al Added: 3 years ago

Intervention

CV Disease in Special Populations
Author(s): Aman Ali , Timothy A Sanborn Added: 3 years ago
Cardiogenic shock (CS) remains the leading cause of death among patients hospitalised for acute myocardial infarction (AMI), with mortality rates of approximately 50%.1 Even with the benefit of thrombolytic therapy and intra-aortic balloon pumps (IABPs), the in-hospital mortality rate of patients with CS from AMI was only lowered from 63 to 47% according to a report from the SHould we emergently… View more

Anticoagulation

Heart Failure
Coronary Artery Disease in Patients with Severe Mental Illness
Author(s): Brian Tam To , Roman Roy , Narbeh Melikian , et al Added: 12 months ago

MI/ACS

CV Disease in Special Populations
TCT 22: RADIANCE II: Paradise Renal Denervation in Pts With Hypertension
Author(s): Ajay J Kirtane Added: 1 year ago
TCT 22 - In this short video from TCT 2022, Dr Ajay Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, NY, US) joins us to discuss the findings of ReCor's RADIANCE II Pivotal trial, which aimed to evaluate the safety and effectiveness of the Paradise renal Denervation System in patients with stage 2 hypertension. 225 patients were randomized to receive either a renal… View more

Prevention & Chronic Conditions

Intervention
TRILUMINATE Pivotal Trial Results
Author(s): Paul Sorajja , Ralph Stephan von Bardeleben , , et al Added: 1 year ago
In this short series of interviews, our faculty discuss the recent TRILUMINATE Pivotal Trial Results. We hear fromone of the lead PI’s on the trial,Dr Paul Sorajja (Abbott Northwestern Hospital, Minneapolis, US), as well as Cardiac Surgeon Dr Vinod Thourani (Piedmont Healthcare, Atlanta, US), Interventionalist Prof Ralph Stephan Von Bardeleben (Heart Valve Centre, Mainz, DE) and Heart… View more

Intervention
Author(s): Vasilis Babaliaros , Peter Block Added: 3 years ago
The principal therapies for valvular heart disease are surgical. Catheter-based treatment, traditionally, has had a limited role in treating stenotic lesions of the mitral, pulmonary and aortic valves. Recently, however, percutaneous valvular intervention has drastically improved, secondary to advances in technology and innovative treatment strategies. With the proven feasibility of percutaneous… View more

Vascular Disease and Surgery

Intervention
HRS
The Heart Rhythm Society (HRS) is a leading resource on cardiac pacing and electrophysiology. This specialty organization represents medical, allied health, and science professionals from more than 70 countries who specialize in cardiac rhythm disorders. Mission: to improve the care of patients by promoting research, education, and optimal health care policies and standards.Vision: to end death… View more